Inventor · disambiguated record
Jamie Spangler
Also filed as: SPANGLER JAMIE · SPANGLER JAMIE B
10 granted patents·9 pending applications·23 citations·filing 2010–2025
86Inventor score
Top patents by PatentIndex Score
19 records- 0196US10844105B2De novo design of potent and selective interleukin mimeticsUNIV WASHINGTON·Filed 2020·Granted Nov 24, 2020·6 cites·30 claims
- 0295US11655278B2De novo design of potent and selective interleukin mimeticsUNIV WASHINGTON·Filed 2021·Granted May 23, 2023·2 cites·20 claims
- 0393US11117944B2De novo design of potent and selective interleukin mimeticsUNIV WASHINGTON·Filed 2020·Granted Sep 14, 2021·5 cites·30 claims
- 0492US11401313B2De novo design of potent and selective interleukin mimeticsUNIV WASHINGTON·Filed 2020·Granted Aug 2, 2022·2 cites·28 claims
- 0592US10703791B2De novo design of potent and selective interleukin mimeticsUNIV WASHINGTON·Filed 2019·Granted Jul 7, 2020·7 cites·29 claims
- 0686US12227553B2De novo design of potent and selective interleukin mimeticsUNIV WASHINGTON·Filed 2023·Granted Feb 18, 2025·0 cites·13 claims
- 0781US12240880B2De novo design of potent and selective interleukin mimeticsUNIV WASHINGTON·Filed 2022·Granted Mar 4, 2025·0 cites·20 claims
- 0877US2025171514A1De novo design of potent and selective interleukin mimeticsUNIV WASHINGTON·Filed 2025·Application pending·0 cites
- 0974US12151000B2Tolerogenic artificial antigen-presenting cellsUNIV JOHNS HOPKINS·Filed 2020·Granted Nov 26, 2024·1 cites·16 claims
- 1064US2025154225A1Mhc ii artificial antigen presenting cells harness the effector and helper functions of antigen-specific cd4+ t cellsUNIV JOHNS HOPKINS·Filed 2022·Application pending·0 cites
- 1155US12492258B2Bispecific binding agentsUNIV JOHNS HOPKINS·Filed 2020·Granted Dec 9, 2025·0 cites·14 claims
- 1253US2025155449A1Recombinant antibodies comprising anti-human immunoglobulin g-invertase fusion proteins and methods of using the sameUNIV JOHNS HOPKINS·Filed 2023·Application pending·0 cites
- 1351US2024279328A1Methods to glycoengineer proteinsUNIV JOHNS HOPKINS·Filed 2021·Application pending·0 cites
- 1449US2023341396A1Methods and related aspects for pathogen detectionUNIV JOHNS HOPKINS·Filed 2021·Application pending·0 cites
- 1546US2022251222A1IL-6Ralpha/IL-8R BISPECIFIC BINDING AGENTS FOR INHIBITING CANCER CELL MIGRATIONUNIV JOHNS HOPKINS·Filed 2020·Application pending·0 cites
- 1643US2022242946A1Methods and materials for targeted expansion of regulatory t cellsUNIV JOHNS HOPKINS·Filed 2020·Application pending·0 cites
- 1738US2022372098A1Methods and materials for targeted expansion of immune effector cellsUNIV JOHNS HOPKINS·Filed 2020·Application pending·0 cites
- 1835US2012270797A1Engineered proteins including mutant fibronectin domainsWITTRUP KARL DANE·Filed 2010·Application pending·0 cites
- 1928US9464136B2Antibody-based constructs directed against tyrosine kinase receptorsWITTRUP KARL DANE·Filed 2011·Granted Oct 11, 2016·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Jamie Spangler files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →